The results indicated that phenethyl isothiocyanate administration caused increased caspase-3 activities in cervical cancer cells as 62.53, 81.89, and 112.06% at 20, 25, and 30 μM, respectively, as compared to the untreated control (Figure 4A). This evidence concerns the gene CASP3 and cervical carcinoma.